138 related articles for article (PubMed ID: 7890240)
1. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.
Smith-Ravin J; England J; Talbot IC; Bodmer W
Gut; 1995 Jan; 36(1):81-6. PubMed ID: 7890240
[TBL] [Abstract][Full Text] [Related]
2. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
3. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
Sidransky D; Tokino T; Hamilton SR; Kinzler KW; Levin B; Frost P; Vogelstein B
Science; 1992 Apr; 256(5053):102-5. PubMed ID: 1566048
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].
Koornstra JJ; Røkke O; Halvorsen JF; Haug K; Ogreid D
Tidsskr Nor Laegeforen; 1995 Oct; 115(26):3266-70. PubMed ID: 7482456
[TBL] [Abstract][Full Text] [Related]
5. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis.
Bell SM; Kelly SA; Hoyle JA; Lewis FA; Taylor GR; Thompson H; Dixon MF; Quirke P
Br J Cancer; 1991 Jul; 64(1):174-8. PubMed ID: 1854618
[TBL] [Abstract][Full Text] [Related]
6. Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
[TBL] [Abstract][Full Text] [Related]
7. Stability of K-ras mutations throughout the natural history of human colorectal cancer.
Losi L; Benhattar J; Costa J
Eur J Cancer; 1992; 28A(6-7):1115-20. PubMed ID: 1627381
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon.
Okulczyk B; Kovalchuk O; Piotrowski Z; Myśliwiec P; Chyczewski L
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():52-4. PubMed ID: 15638373
[TBL] [Abstract][Full Text] [Related]
11. [Detection of K-ras point mutations in the stool of patients with colorectal tumors].
Kohata Y
Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):391-7. PubMed ID: 8752756
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
Caduff RF; Johnston CM; Frank TS
Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
[TBL] [Abstract][Full Text] [Related]
13. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
[TBL] [Abstract][Full Text] [Related]
14. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
Xu KM
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells.
Puig P; Urgell E; Capellá G; Villanueva A; Grau M; Sancho FJ; Pujol J; Lluís F; González-Sastre F; Mora J
Lab Invest; 1999 May; 79(5):617-8. PubMed ID: 10334573
[No Abstract] [Full Text] [Related]
16. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
17. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
18. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
Lee JC; Wang ST; Lai MD; Lin YJ; Yang HB
Anticancer Res; 1996; 16(6B):3839-44. PubMed ID: 9042267
[TBL] [Abstract][Full Text] [Related]
19. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance.
Morrin M; Kelly M; Barrett N; Delaney P
Gut; 1994 Nov; 35(11):1627-31. PubMed ID: 7828987
[TBL] [Abstract][Full Text] [Related]
20. [Genetic heterogeneity of certain sporadic colorectal cancers].
Vincent-Salomon A; Olschwang S; Hamelin R; Remvikos Y; Laurent-Puig P; Thomas G
Gastroenterol Clin Biol; 1993; 17(10):733-9. PubMed ID: 8288082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
